Bioasis Technologies (FRA:107) Price-to-Operating-Cash-Flow : (As of Jun. 20, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Bioasis Technologies Price-to-Operating-Cash-Flow?

As of today (2024-06-20), Bioasis Technologies's share price is €0.008. Bioasis Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2022 was €-0.02. Hence, Bioasis Technologies's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Bioasis Technologies's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:107's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.955
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Bioasis Technologies's Cash Flow from Operations per share for the three months ended in Nov. 2022 was €-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2022 was €-0.02.

Bioasis Technologies Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Bioasis Technologies's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioasis Technologies Price-to-Operating-Cash-Flow Chart

Bioasis Technologies Annual Data

Trend

Feb13

Feb14

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

13.85

Bioasis Technologies Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Bioasis Technologies's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Bioasis Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's Price-to-Operating-Cash-Flow falls into.

Bioasis Technologies Price-to-Operating-Cash-Flow Calculation

Bioasis Technologies's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.008	/	-0.019
	=

Bioasis Technologies's Share Price of today is €0.008.
Bioasis Technologies's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Bioasis Technologies Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Bioasis Technologies's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioasis Technologies (FRA:107) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioasis Technologies Inc (FRA:107) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

157 Church Street, 19th Floor, New Haven, CT, USA, 06510

Website

https://www.bioasis.us

Bioasis Technologies Inc is a development stage biopharmaceutical company. It is engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company has worked on a blood-brain barrier program and studies disorders in the brain. The company's xB3 program describes its proprietary carrier, for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The company's in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Bioasis Technologies (FRA:107) Headlines

No Headlines